Detalles de la búsqueda
1.
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
Am J Hematol
; 96(6): 708-718, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33755235
2.
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk.
Am J Hematol
; 96(9): 1120-1130, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34062004
3.
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study.
Am J Hematol
; 97(3): E83-E86, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882831
4.
Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.
Am J Hematol
; 96(10): E383-E386, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161627
5.
Diversity of small round cell sarcoma in soft tissues around bone among Indian patients.
Bioinformation
; 19(8): 871-875, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37908610
6.
Genomic Pattern of GSTM1 and T1 Gene Null polymorphism of Head and Neck Cancer Patients in Eastern India.
Asian Pac J Cancer Prev
; 23(8): 2655-2659, 2022 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037119
7.
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer.
World J Gastrointest Surg
; 14(11): 1272-1284, 2022 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36504513
8.
Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes.
J Cancer Res Ther
; 18(4): 903-906, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149138
Resultados
1 -
8
de 8
1
Próxima >
>>